Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
1.980
-0.020 (-1.00%)
At close: Apr 28, 2026, 4:00 PM EDT
2.010
+0.030 (1.52%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $77.50 million as of April 28, 2026. Its market cap has decreased by -36.68% in one year.
Market Cap
77.50M
Enterprise Value
-15.94M
1-Year Change
-36.68%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $77.50M, a decrease of -84.12%. That is a compound annual growth rate of -31.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 78.68M | -30.90% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Micro Biosystems | 110.30M |
| MaxCyte | 90.96M |
| Outset Medical | 80.02M |
| QT Imaging Holdings | 79.48M |
| Xtant Medical Holdings | 74.07M |
| Sensus Healthcare | 65.19M |
| LENSAR | 63.02M |
| Baird Medical Investment Holdings | 62.43M |